Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation

Aldemar Montero(UConn Health), Yosuke Okada(UConn Health), Masato Tomita(UConn Health), Masako Ito(Nagasaki University), Hiroshi Tsurukami(University of Occupational and Environmental Health Japan), Toshitaka Nakamura(University of Occupational and Environmental Health Japan), Thomas Doetschman(University of Cincinnati), J. Douglas Coffin(University of Montana), Marja M. Hurley(UConn Health)
Journal of Clinical Investigation
April 15, 2000
Cited by 475Open Access
Full Text

Abstract

Basic fibroblast growth factor (FGF-2), an important modulator of cartilage and bone growth and differentiation, is expressed and regulated in osteoblastic cells. To investigate the role of FGF-2 in bone, we examined mice with a disruption of the Fgf2 gene. Measurement of trabecular bone architecture of the femoral metaphysis of Fgf2(+/+) and Fgf2(-/-) adult mice by micro-CT revealed that the platelike trabecular structures were markedly reduced and many of the connecting rods of trabecular bone were lost in the Fgf2(-/-) mice. Dynamic histomorphometry confirmed a significant decrease in trabecular bone volume, mineral apposition, and bone formation rates. In addition, there was a profound decreased mineralization of bone marrow stromal cultures from Fgf2(-/-) mice. This study provides strong evidence that FGF-2 helps determine bone mass as well as bone formation.


Related Papers

No related papers found

Powered by citation graph analysis